Page last updated: 2024-10-22

6-acetylaminocaproic acid and Anasarca

6-acetylaminocaproic acid has been researched along with Anasarca in 2 studies

6-acetylaminocaproic acid: wound-healing agent component of plasmutan

Research Excerpts

ExcerptRelevanceReference
" The time of peak concentration value for complexed piroxicam was 5."1.30Pharmacokinetic profile and adverse gastric effect of zinc-piroxicam in rats. ( Kimura, E; Nothenberg, MS; Oga, S; Santos, SR; Tagliati, CA, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tagliati, CA1
Kimura, E1
Nothenberg, MS1
Santos, SR1
Oga, S1
Bravo, L1
Escolar, G1
Navarro, C1
Fontarnau, R1
Bulbena, O1

Other Studies

2 other studies available for 6-acetylaminocaproic acid and Anasarca

ArticleYear
Pharmacokinetic profile and adverse gastric effect of zinc-piroxicam in rats.
    General pharmacology, 1999, Volume: 33, Issue:1

    Topics: Aminocaproates; Aminocaproic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agen

1999
Effect of zinc acexamate on gastric lesions induced by aspirin: a morphological study.
    European journal of pharmacology, 1990, Nov-06, Volume: 190, Issue:1-2

    Topics: Aminocaproates; Aminocaproic Acid; Animals; Anti-Ulcer Agents; Aspirin; Carrageenan; Chromatography,

1990